Your browser doesn't support javascript.
loading
Development of individualized treatment for congenital ovarian dysplasia syndrome / 中华实用儿科临床杂志
Chinese Journal of Applied Clinical Pediatrics ; (24): 1591-1594, 2019.
Article Dans Chinois | WPRIM | ID: wpr-803097
ABSTRACT
Congenital ovarian dysplasia syndrome is a feminine genetic disease which is rarely seen.Its clinical manifestations include short stature and primary ovarian insufficiency, in addition of which could cause multi-systema-tic complications.According to its therapeutic methods, recombinant human growth hormone and Estrogen are normally used to improve stature and the development of gonad.However, these methods are long-lasting and with great expense, which may result in economic and emotional burdens on patients and their family.On the contrary, individual therapies has a rather precise pharmacogenetical evaluation on patients and their disease, which could effectively decrease iatrogenic loss while enhancing the curative effect.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Applied Clinical Pediatrics Année: 2019 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Applied Clinical Pediatrics Année: 2019 Type: Article